Vanguard reports 7.45% stake in CME Group
CME Group Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 27,044,709 shares of Common Stock, equal to 7.45% of the class as reported for the period ending 03/31/2026.
Rhea-AI Filing Summary
CME Group Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 27,044,709 shares of Common Stock, equal to 7.45% of the class as reported for the period ending 03/31/2026.
The filing states Vanguard has sole dispositive power over 27,044,709 shares and sole voting power for 3,677,427 shares. The filing describes holdings held on behalf of various Vanguard affiliates and funds. Signature on the filing is dated 04/29/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard holds a sizeable passive stake of 7.45% in CME Group as of 03/31/2026.
Vanguard Capital Management reports beneficial ownership of 27,044,709 shares with sole dispositive authority and limited sole voting power. The disclosure identifies multiple Vanguard affiliates and indicates these shares include fund and managed-account holdings.
Implications depend on trading decisions by underlying funds and affiliates; cash‑flow treatment and any planned transactions are not stated in the excerpt.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Are Vanguard's CME holdings held on behalf of other Vanguard affiliates or funds?
What date does the ownership percentage refer to in the filing?
Does the Schedule 13G disclose any planned sales or purchases by Vanguard in CME stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.